Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Hui Jiang & Zhuping Xu. (2023) Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment. Drug Delivery 30:1.
Read now
Read now
Articles from other publishers (29)
Rui Wang, Yingying Li, Shan Gao, Yu Zhang, Zhijing He, Jianbo Ji, Xiaoye Yang, Lei Ye, Lixia Zhao, Anchang Liu & Guangxi Zhai. (2024) An active transport dual adaptive nanocarrier designed to overcome the corneal microenvironment for neovascularization therapy. Biomaterials Science.
Crossref
Crossref
Arpon Biswas, Abhijit Deb Choudhury, Amol Chhatrapati Bisen, Sristi Agrawal, Sachin Nashik Sanap, Sarvesh Kumar Verma, Anjali Mishra, Shivansh Kumar & Rabi Sankar Bhatta. (2023) Trends in Formulation Approaches for Sustained Drug Delivery to the Posterior Segment of the Eye. AAPS PharmSciTech 24:8.
Crossref
Crossref
Rosario Amato, Alberto Melecchi, Laura Pucci, Alessio Canovai, Silvia Marracci, Maurizio Cammalleri, Massimo Dal Monte, Carla Caddeo & Giovanni Casini. (2023) Liposome-Mediated Delivery Improves the Efficacy of Lisosan G against Retinopathy in Diabetic Mice. Cells 12:20, pages 2448.
Crossref
Crossref
Zhuhong Zhang, Shengjun Peng, Tengyan Xu, Jia Liu, Laien Zhao, Hui Xu, Wen Zhang, Yuanying Zhu & Zhimou Yang. (2023) Retinal Microenvironment‐Protected Rhein‐GFFYE Nanofibers Attenuate Retinal Ischemia‐Reperfusion Injury via Inhibiting Oxidative Stress and Regulating Microglial/Macrophage M1/M2 Polarization. Advanced Science 10:30.
Crossref
Crossref
Qi Qi, Yidan Wei, Xin Zhang, Jian Guan & Shirui Mao. (2023) Challenges and strategies for ocular posterior diseases therapy via non-invasive advanced drug delivery. Journal of Controlled Release 361, pages 191-211.
Crossref
Crossref
Seyed Amin Ayatollahi Mousavi, Abnoos Mokhtari, Mahmood Barani, Alireza Izadi, Alireza Amirbeigi, Narges Ajalli, Azam Amanizadeh & Sanaz Hadizadeh. (2023) Advances of liposomal mediated nanocarriers for the treatment of dermatophyte infections. Heliyon 9:8, pages e18960.
Crossref
Crossref
Ying Tian, Tao Zhang, Jing Li & Yong Tao. (2023) Advances in development of exosomes for ophthalmic therapeutics. Advanced Drug Delivery Reviews 199, pages 114899.
Crossref
Crossref
Avin Sapowadia, Delaram Ghanbariamin, Libo Zhou, Qifa Zhou, Tannin Schmidt, Ali Tamayol & Yupeng Chen. (2023) Biomaterial Drug Delivery Systems for Prominent Ocular Diseases. Pharmaceutics 15:7, pages 1959.
Crossref
Crossref
Xingru Peng, Tingting Zhang, Rui Liu & Xin Jin. (2023) Potential in exosome-based targeted nano-drugs and delivery vehicles for posterior ocular disease treatment: from barriers to therapeutic application. Molecular and Cellular Biochemistry.
Crossref
Crossref
Andrea Gabai, Marco Zeppieri, Lucia Finocchio & Carlo Salati. (2023) Innovative Strategies for Drug Delivery to the Ocular Posterior Segment. Pharmaceutics 15:7, pages 1862.
Crossref
Crossref
Noriyasu Hashida & Kohji Nishida. (2023) Recent advances and future prospects: Current status and challenges of the intraocular injection of drugs for vitreoretinal diseases. Advanced Drug Delivery Reviews 198, pages 114870.
Crossref
Crossref
Laien Zhao, Longbing Ling, Jing Lu, Feng Jiang, Jianchao Sun, Zhen Zhang, Yanmei Huang, Xiaoqian Liu, Yanjuan Zhu, Xiaoxuan Fu, Shengjun Peng, Wenze Yuan, Ruikang Zhao & Zhuhong Zhang. (2022)
Reactive oxygen species‐responsive mitochondria‐targeted liposomal quercetin attenuates retinal ischemia–reperfusion injury via regulating
SIRT1
/
FOXO3A
and p38
MAPK
signaling pathways
. Bioengineering & Translational Medicine 8:3.
Crossref
Crossref
Charis Rousou, Nicky van Kronenburg, Andreas F. P. Sonnen, Marijke van Dijk, Chrit Moonen, Gert Storm, Enrico Mastrobattista & Roel Deckers. (2023) Microbubble-Assisted Ultrasound for Drug Delivery to the Retina in an Ex Vivo Eye Model. Pharmaceutics 15:4, pages 1220.
Crossref
Crossref
Raquel da Ana, Anna Gliszczyńska, Elena Sanchez-Lopez, Maria L. Garcia, Karolline Krambeck, Andjelka Kovacevic & Eliana B. Souto. (2023) Precision Medicines for Retinal Lipid Metabolism-Related Pathologies. Journal of Personalized Medicine 13:4, pages 635.
Crossref
Crossref
Viliana Gugleva & Velichka Andonova. (2023) Recent Progress of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Ocular Drug Delivery Platforms. Pharmaceuticals 16:3, pages 474.
Crossref
Crossref
Amal H. El-Kamel & Asmaa A. Ashour. 2023. Advanced Drug Delivery Systems. Advanced Drug Delivery Systems.
Nikita Kaushal, Manish Kumar, Amanjot Singh, Abhishek Tiwari, Varsha Tiwari & Rakesh Pahwa. (2023) A Review on Polymeric Nanostructured Micelles for the Ocular
Inflammation-Main Emphasis on Uveitis. Pharmaceutical Nanotechnology 11:1, pages 34-43.
Crossref
Crossref
Adaeze Linda Onugwu, Chinekwu Sherridan Nwagwu, Obinna Sabastine Onugwu, Adaeze Chidiebere Echezona, Chinazom Precious Agbo, Stella Amarachi Ihim, Prosper Emeh, Petra Obioma Nnamani, Anthony Amaechi Attama & Vitaliy V. Khutoryanskiy. (2023) Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases. Journal of Controlled Release 354, pages 465-488.
Crossref
Crossref
Yun-Yi Cong, Bin Fan, Zi-Yuan Zhang & Guang-Yu Li. (2023) Implantable sustained-release drug delivery systems: a revolution for ocular therapeutics. International Ophthalmology 43:7, pages 2575-2588.
Crossref
Crossref
Xuan Chen, Rui Yang, Jinyan Shen, Qingyu Huang & Zhifeng Wu. (2023) Research Progress of Bioinspired Nanostructured Systems for the Treatment of Ocular Disorders. Pharmaceuticals 16:1, pages 96.
Crossref
Crossref
Raquel da Ana, Joel Fonseca, Jacek Karczewski, Amélia M. Silva, Aleksandra Zielińska & Eliana B. Souto. (2022) Lipid-Based Nanoparticulate Systems for the Ocular Delivery of Bioactives with Anti-Inflammatory Properties. International Journal of Molecular Sciences 23:20, pages 12102.
Crossref
Crossref
Biswarup Das, Amit Kumar Nayak & Subrata Mallick. (2022) Lipid-based nanocarriers for ocular drug delivery: An updated review. Journal of Drug Delivery Science and Technology 76, pages 103780.
Crossref
Crossref
Wissam Farhat, Vincent Yeung, Amy Ross, Francesca Kahale, Nikolay Boychev, Liangju Kuang, Lin Chen & Joseph B. Ciolino. (2022) Advances in biomaterials for the treatment of retinoblastoma. Biomaterials Science 10:19, pages 5391-5429.
Crossref
Crossref
Ahmed Salman, Ariel Kantor, Michelle E. McClements, Gemma Marfany, Sonia Trigueros & Robert E. MacLaren. (2022) Non-Viral Delivery of CRISPR/Cas Cargo to the Retina Using Nanoparticles: Current Possibilities, Challenges, and Limitations. Pharmaceutics 14:9, pages 1842.
Crossref
Crossref
Cao Yang, Junling Yang, Ao Lu, Jing Gong, Yuanxing Yang, Xi Lin, Minghui Li & Haiwei Xu. (2022) Nanoparticles in ocular applications and their potential toxicity. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Cheng-Han Tsai, Le Ngoc Hoang, Chun Che Lin, Liang-Chen Pan, Chiao-Li Wu, I-Chan Lin, Peng-Yuan Wang & Ching-Li Tseng. (2022) Evaluation of Topical and Subconjunctival Injection of Hyaluronic Acid-Coated Nanoparticles for Drug Delivery to Posterior Eye. Pharmaceutics 14:6, pages 1253.
Crossref
Crossref
Tingting Zhang, Xin Jin, Nan Zhang, Xinyi Jiao, Yuanyuan Ma, Rui Liu, Boshi Liu & Zheng Li. (2022) Targeted drug delivery vehicles mediated by nanocarriers and aptamers for posterior eye disease therapeutics: barriers, recent advances and potential opportunities. Nanotechnology 33:16, pages 162001.
Crossref
Crossref
Evangelos Natsaridis, Foteini Gkartziou, Spyridon Mourtas, Marc C. A. Stuart, Fevronia Kolonitsiou, Pavlos Klepetsanis, Iris Spiliopoulou & Sophia G. Antimisiaris. (2022) Moxifloxacin Liposomes: Effect of Liposome Preparation Method on Physicochemical Properties and Antimicrobial Activity against Staphylococcus epidermidis. Pharmaceutics 14:2, pages 370.
Crossref
Crossref
Lorena Bonilla, Marta Espina, Patricia Severino, Amanda Cano, Miren Ettcheto, Antoni Camins, Maria Luisa García, Eliana B. Souto & Elena Sánchez-López. (2021) Lipid Nanoparticles for the Posterior Eye Segment. Pharmaceutics 14:1, pages 90.
Crossref
Crossref